A detailed history of Zions Bancorporation, N.A. transactions in Novo Nordisk A S stock. As of the latest transaction made, Zions Bancorporation, N.A. holds 18,535 shares of NVO stock, worth $1.9 Million. This represents 0.16% of its overall portfolio holdings.

Number of Shares
18,535
Previous 11,809 56.96%
Holding current value
$1.9 Million
Previous $1.69 Million 30.92%
% of portfolio
0.16%
Previous 0.14%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 06, 2024

BUY
$119.07 - $145.42 $800,864 - $978,094
6,726 Added 56.96%
18,535 $2.21 Million
Q2 2024

Aug 08, 2024

SELL
$122.71 - $146.91 $237,321 - $284,123
-1,934 Reduced 14.07%
11,809 $1.69 Million
Q1 2024

May 14, 2024

SELL
$102.11 - $135.92 $54,220 - $72,173
-531 Reduced 3.72%
13,743 $1.76 Million
Q4 2023

Feb 12, 2024

BUY
$87.78 - $105.45 $167,133 - $200,776
1,904 Added 15.39%
14,274 $1.48 Million
Q3 2023

Nov 07, 2023

BUY
$90.94 - $199.54 $758,075 - $1.66 Million
8,336 Added 206.64%
12,370 $1.12 Million
Q2 2023

Jul 28, 2023

BUY
$155.98 - $172.65 $414,438 - $458,731
2,657 Added 192.96%
4,034 $652,000
Q1 2023

May 10, 2023

SELL
$132.34 - $159.14 $69,346 - $83,389
-524 Reduced 27.56%
1,377 $219,000
Q4 2022

Feb 10, 2023

BUY
$102.55 - $135.33 $29,739 - $39,245
290 Added 18.0%
1,901 $257,000
Q3 2022

Nov 08, 2022

SELL
$95.28 - $116.93 $13,815 - $16,954
-145 Reduced 8.26%
1,611 $161,000
Q2 2022

Aug 05, 2022

SELL
$103.24 - $121.81 $103 - $121
-1 Reduced 0.06%
1,756 $196,000
Q1 2022

May 13, 2022

BUY
$93.1 - $112.54 $6,703 - $8,102
72 Added 4.27%
1,757 $195,000
Q3 2021

Nov 10, 2021

SELL
$84.42 - $106.62 $74,120 - $93,612
-878 Reduced 34.26%
1,685 $161,000
Q2 2021

Aug 11, 2021

BUY
$67.66 - $84.76 $60,352 - $75,605
892 Added 53.38%
2,563 $215,000
Q1 2021

May 13, 2021

BUY
$67.06 - $75.82 $14,686 - $16,604
219 Added 15.08%
1,671 $112,000
Q4 2020

Feb 12, 2021

BUY
$63.89 - $73.8 $2,491 - $2,878
39 Added 2.76%
1,452 $101,000
Q3 2020

Nov 13, 2020

SELL
$63.69 - $70.22 $891 - $983
-14 Reduced 0.98%
1,413 $98,000
Q2 2020

Aug 13, 2020

SELL
$58.54 - $67.94 $1,170 - $1,358
-20 Reduced 1.38%
1,427 $93,000
Q1 2020

May 15, 2020

SELL
$49.46 - $64.78 $37,045 - $48,520
-749 Reduced 34.11%
1,447 $87,000
Q4 2019

Feb 14, 2020

SELL
$49.86 - $58.26 $1,246 - $1,456
-25 Reduced 1.13%
2,196 $127,000
Q3 2019

Nov 13, 2019

SELL
$47.54 - $53.43 $1,996 - $2,244
-42 Reduced 1.86%
2,221 $115,000
Q2 2019

Jul 09, 2019

SELL
$46.79 - $52.47 $23,161 - $25,972
-495 Reduced 17.95%
2,263 $116,000
Q1 2019

May 10, 2019

BUY
$46.36 - $52.63 $127,860 - $145,153
2,758 New
2,758 $144,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $232B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Zions Bancorporation, N.A. Portfolio

Follow Zions Bancorporation, N.A. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Zions Bancorporation, N.A., based on Form 13F filings with the SEC.

News

Stay updated on Zions Bancorporation, N.A. with notifications on news.